Skip to main content
Erschienen in: Current Treatment Options in Neurology 3/2011

01.06.2011 | Neuroimmunology

Anti–NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders

verfasst von: Myrna R. Rosenfeld, MD, PhD, Josep Dalmau, MD, PhD

Erschienen in: Current Treatment Options in Neurology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Opinion statement

Synaptic autoimmunity may result in a wide variety of symptoms, including catatonia, psychosis, movement disorders, short-term memory deficits, and refractory seizures, so these patients are seen by a wide spectrum of practitioners, who need to be aware of these disorders. In some cases, these disorders occur as a paraneoplastic manifestation of an associated cancer. However, in contrast to the well-known paraneoplastic neurologic disorders of the central nervous system that predominate in older individuals, these novel disorders often affect children and young adults. Additionally, for some syndromes, the presence of a tumor does not necessarily indicate a poor prognosis. Successful treatment of the tumor and immunotherapy often result in recovery, supporting the use of surgery for severely ill patients. In all syndromes, deficits may be reversible despite the duration or severity of symptoms. For example, patients with anti–NMDA-receptor encephalitis who had been in a coma or ventilated for 6–10 months have had full recovery after appropriate treatment.
Literatur
1.
Zurück zum Zitat Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36.PubMedCrossRef Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36.PubMedCrossRef
2.•
Zurück zum Zitat Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424–34.PubMedCrossRef Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424–34.PubMedCrossRef
3.••
Zurück zum Zitat Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9:776–85.PubMedCrossRef Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9:776–85.PubMedCrossRef
4.
Zurück zum Zitat Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis. 2009;28:1421–9.PubMedCrossRef Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis. 2009;28:1421–9.PubMedCrossRef
5.
Zurück zum Zitat Dale RC, Irani SR, Brilot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009;66:704–9.PubMedCrossRef Dale RC, Irani SR, Brilot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009;66:704–9.PubMedCrossRef
6.
Zurück zum Zitat Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58:594–604.PubMedCrossRef Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58:594–604.PubMedCrossRef
7.••
Zurück zum Zitat Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091–8.PubMedCrossRef Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091–8.PubMedCrossRef
8.••
Zurück zum Zitat Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11–8.PubMedCrossRef Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11–8.PubMedCrossRef
9.•
Zurück zum Zitat Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008;70:504–11.PubMedCrossRef Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008;70:504–11.PubMedCrossRef
10.
Zurück zum Zitat Wandinger K-P, Saschenbrecker S, Stoecker W, Dalmau J Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol. 2010 Oct 14 (Epub ahead of print). Wandinger K-P, Saschenbrecker S, Stoecker W, Dalmau J Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol. 2010 Oct 14 (Epub ahead of print).
11.
Zurück zum Zitat Ferioli S, Dalmau J, Kobet CA, et al. Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder. Arch Neurol. 2010;67:250–1.PubMedCrossRef Ferioli S, Dalmau J, Kobet CA, et al. Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder. Arch Neurol. 2010;67:250–1.PubMedCrossRef
12.
Zurück zum Zitat Bataller L, Galiano R, Garcia-Escrig M, et al. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology. 2010;74:265–7.PubMedCrossRef Bataller L, Galiano R, Garcia-Escrig M, et al. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology. 2010;74:265–7.PubMedCrossRef
13.••
Zurück zum Zitat Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9:67–76.PubMedCrossRef Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9:67–76.PubMedCrossRef
14.
Zurück zum Zitat Boronat A, Sabater L, Saiz A, Dalmau J, Graus F GABA(B) receptor antibodies in limbic encephalitis and anti-GAD associated neurological disorders. Neurology. 2010;(in press). Boronat A, Sabater L, Saiz A, Dalmau J, Graus F GABA(B) receptor antibodies in limbic encephalitis and anti-GAD associated neurological disorders. Neurology. 2010;(in press).
15.
Zurück zum Zitat Andrade DM, Tai P, Dalmau J, Wennberg R Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis. Neurology. 2010;(in press). Andrade DM, Tai P, Dalmau J, Wennberg R Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis. Neurology. 2010;(in press).
16.
Zurück zum Zitat Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain. 2010;133:2734–48.PubMedCrossRef Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain. 2010;133:2734–48.PubMedCrossRef
17.
Zurück zum Zitat Gu W, Brodtkorb E, Steinlein OK LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol. 2002;52:364–7.PubMedCrossRef Gu W, Brodtkorb E, Steinlein OK LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol. 2002;52:364–7.PubMedCrossRef
18.
Zurück zum Zitat Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet. 2002;30:335–41.PubMedCrossRef Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet. 2002;30:335–41.PubMedCrossRef
19.
Zurück zum Zitat Breese EH, Dalmau J, Lennon VA, Apiwattanakul M, Sokol DK: Anti-N-methyl-D-aspartate receptor encephalitis: early treatment is beneficial. Pediatr Neurol. 2010;42:213–4.PubMedCrossRef Breese EH, Dalmau J, Lennon VA, Apiwattanakul M, Sokol DK: Anti-N-methyl-D-aspartate receptor encephalitis: early treatment is beneficial. Pediatr Neurol. 2010;42:213–4.PubMedCrossRef
20.
Zurück zum Zitat Seki M, Suzuki S, Iizuka T, et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry. 2008;79:324–6.PubMedCrossRef Seki M, Suzuki S, Iizuka T, et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry. 2008;79:324–6.PubMedCrossRef
21.
Zurück zum Zitat Ishiura H, Matsuda S, Higashihara M, et al. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology. 2008;71:1921–3.PubMedCrossRef Ishiura H, Matsuda S, Higashihara M, et al. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology. 2008;71:1921–3.PubMedCrossRef
22.
Zurück zum Zitat Wong-Kisiel LC, Ji T, Renaud DL, et al. Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.Neurology. 2010;74:1550–1.PubMedCrossRef Wong-Kisiel LC, Ji T, Renaud DL, et al. Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.Neurology. 2010;74:1550–1.PubMedCrossRef
23.
Zurück zum Zitat Prüss H, Dalmau J, Harms L, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010;75:1735–9.PubMedCrossRef Prüss H, Dalmau J, Harms L, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010;75:1735–9.PubMedCrossRef
Metadaten
Titel
Anti–NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders
verfasst von
Myrna R. Rosenfeld, MD, PhD
Josep Dalmau, MD, PhD
Publikationsdatum
01.06.2011
Verlag
Current Science Inc.
Erschienen in
Current Treatment Options in Neurology / Ausgabe 3/2011
Print ISSN: 1092-8480
Elektronische ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-011-0116-y

Weitere Artikel der Ausgabe 3/2011

Current Treatment Options in Neurology 3/2011 Zur Ausgabe

Neuroimmunology

Behçet’s Disease

Movement Disorders

Tardive Dyskinesia

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.